Laquinimod Slows Progression in MS: ALLEGRO Published - Medscape

[**Laquinimod Slows Progression in MS: ALLEGRO Published**][1]
**Medscape**
March 14, 2012 — Results of a phase 3 randomized trial show treatment with laquinimod, a still-investigational oral agent, reduced annualized relapse rates and delayed **disability** progression compared with placebo in patients with relapsing-remitting **...**
[Experimental Pill May Ease Multiple Sclerosis **Disability**][2]U.S. News & World Report

[**all 5 news articles »**][3]

[1]: http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHzvK4WlPt4nhSHmVowTZyWzMjdDg&url=http://www.medscape.com/viewarticle/760254
[2]: http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHK9p--OU_0C1azFkPypHoGn4Lm2Q&url=http://health.usnews.com/health-news/news/articles/2012/03/14/experimental-pill-may-ease-multiple-sclerosis-disability
[3]: http://news.google.com/news/more?gl=us&pz=1&ned=us&ncl=dVSnFJAnYoys6fMiH3s04r_5I0KXM

URL: http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHzvK4WlPt4nhSHmVowTZyWzMjdDg&url=http://www.medscape.com/viewarticle/760254